Raiffeisen Bank International Ag Argenx Se Put Options Transaction History
Raiffeisen Bank International Ag
- $6.27 Trillion
- Q1 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ARGX
# of Institutions
497Shares Held
28.5MCall Options Held
330KPut Options Held
286K-
Price T Rowe Associates Inc Baltimore, MD5.38MShares$3.11 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$1.61 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.14MShares$1.24 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.94MShares$1.12 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$714 Million11.83% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $32B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...